Cargando…

Management of sulfonylurea‐treated monogenic diabetes in pregnancy: implications of placental glibenclamide transfer

The optimum treatment for HNF1A/HNF4A maturity‐onset diabetes of the young and ATP‐sensitive potassium (K(ATP)) channel neonatal diabetes, outside pregnancy, is sulfonylureas, but there is little evidence regarding the most appropriate treatment during pregnancy. Glibenclamide has been widely used i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shepherd, M., Brook, A. J., Chakera, A. J., Hattersley, A. T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612398/ https://www.ncbi.nlm.nih.gov/pubmed/28556992 http://dx.doi.org/10.1111/dme.13388

Ejemplares similares

Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes
por: Babiker, Tarig, et al.
Publicado: (2016)

Noninvasive Fetal Genotyping by Droplet Digital PCR to Identify Maternally Inherited Monogenic Diabetes Variants
por: Caswell, Richard C., et al.
Publicado: (2020)

Role of Sulfonylurea Receptor 1 and Glibenclamide in Traumatic Brain Injury: A Review of the Evidence
por: Jha, Ruchira M., et al.
Publicado: (2020)

Precision diabetes: learning from monogenic diabetes
por: Hattersley, Andrew T., et al.
Publicado: (2017)

Tooth Discoloration in Patients With Neonatal Diabetes After Transfer Onto Glibenclamide: A previously unreported side effect
por: Kumaraguru, Janani, et al.
Publicado: (2009)

Incretin hormone responses to carbohydrate and protein/fat are preserved in adults with sulfonylurea‐treated KCNJ11 neonatal diabetes
por: Bowman, Pamela, et al.
Publicado: (2023)

Improved genetic testing for monogenic diabetes using targeted next-generation sequencing
por: Ellard, S., et al.
Publicado: (2013)

Strategies to identify individuals with monogenic diabetes: results of an economic evaluation
por: Peters, Jaime L, et al.
Publicado: (2020)

A diagnostic approach for defining idiopathic remitting diabetes: a retrospective cohort study
por: Babiker, Tarig, et al.
Publicado: (2014)

Diagnosis and management of glucokinase monogenic diabetes in pregnancy: current perspectives
por: Rudland, Victoria L
Publicado: (2019)

Patterns of postmeal insulin secretion in individuals with sulfonylurea-treated KCNJ11 neonatal diabetes show predominance of non-K(ATP)-channel pathways
por: Bowman, Pamela, et al.
Publicado: (2019)

Pharmacokinetic interaction of curcumin and glibenclamide in diabetic rats
por: Devi, P. R. Sakunthala, et al.
Publicado: (2015)

Glibenclamide Prevents Diabetes in NOD Mice
por: Lamprianou, Smaragda, et al.
Publicado: (2016)

Systematic Review of Treatment of Beta-Cell Monogenic Diabetes
por: Naylor, Rochelle N., et al.
Publicado: (2023)

Pioglitazone and sulfonylureas: effectively treating type 2 diabetes
por: Hanefeld, M
Publicado: (2007)

Successful Transition From Insulin to Sulfonylurea Therapy in a Patient With Monogenic Neonatal Diabetes Owing to a KCNJ11 P333L Mutation
por: Philla, Katherine Q., et al.
Publicado: (2013)

Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus – International Task Force
por: Kalra, Sanjay, et al.
Publicado: (2018)

Syndromic monogenic diabetes genes should be tested in patients with a clinical suspicion of MODY
por: Colclough, Kevin, et al.
Publicado: (2022)

Incidence of Bladder Cancer in Patients With Type 2 Diabetes Treated With Metformin or Sulfonylureas
por: Mamtani, Ronac, et al.
Publicado: (2014)

Bringing precision medicine to the management of pregnancy in women with glucokinase-MODY: a study of diagnostic accuracy and feasibility of non-invasive prenatal testing
por: Hughes, Alice E., et al.
Publicado: (2023)

Learning From Molecular Genetics: Novel Insights Arising From the Definition of Genes for Monogenic and Type 2 Diabetes
por: McCarthy, Mark I., et al.
Publicado: (2008)

Commentary on “Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus: International Task Force”
por: Singh, S. K.
Publicado: (2018)

Glibenclamide for the Treatment of Ischemic and Hemorrhagic Stroke
por: Caffes, Nicholas, et al.
Publicado: (2015)

Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019
por: Louchet, Margaux, et al.
Publicado: (2020)

Successful Transition From Insulin to Sulfonylurea Therapy in a Patient With Monogenic Neonatal Diabetes Owing to a KCNJ11 P333L Mutation. Diabetes Care 2013;36:e201
por: Philla, Katherine Q., et al.
Publicado: (2014)

Glibenclamide for the Treatment of Acute CNS Injury
por: Kurland, David B., et al.
Publicado: (2013)

ISPAD Clinical Practice Consensus Guidelines 2022: The diagnosis and management of monogenic diabetes in children and adolescents
por: Greeley, Siri Atma W., et al.
Publicado: (2022)

Many faces of monogenic diabetes
por: Schwitzgebel, Valerie M
Publicado: (2014)

Update on Monogenic Diabetes in Korea
por: Yang, Ye Seul, et al.
Publicado: (2020)

Glibenclamide dose response in patients with septic shock
por: Morelli, A, et al.
Publicado: (2007)

Diabetes mellitus in the young: Gliptins or sulfonylurea after metformin?
por: Muthukrishnan, J., et al.
Publicado: (2012)

IgG Placental Transfer in Healthy and Pathological Pregnancies
por: Palmeira, Patricia, et al.
Publicado: (2012)

Comment on: Khurana et al. The Diagnosis of Neonatal Diabetes in a Mother at 25 Years of Age. Diabetes Care 2012;35:e59
por: Chakera, Ali J., et al.
Publicado: (2013)

Sulfonylureas: Asset or liability?
por: Lakhani, Om J., et al.
Publicado: (2015)

Interaction of Herbs and Glibenclamide: A Review
por: Rai, Amita, et al.
Publicado: (2012)

A type 1 diabetes genetic risk score can discriminate monogenic autoimmunity with diabetes from early-onset clustering of polygenic autoimmunity with diabetes
por: Johnson, Matthew B., et al.
Publicado: (2018)

Development of Osteoarthritis in Adults With Type 2 Diabetes Treated With Metformin vs a Sulfonylurea
por: Baker, Matthew C., et al.
Publicado: (2023)

Sulfonylurea: Personalized Medicine for Type 2 Diabetes
por: Hwang, You-Cheol
Publicado: (2015)

Glibenclamide attenuates myocardial injury by lipopolysaccharides in streptozotocin-induced diabetic mice
por: Cai, Jian, et al.
Publicado: (2014)

Comparison of Glibenclamide and Insulin on Neonatal Outcomes in Pregnant Women with Gestational Diabetes
por: Behrashi, Mitra, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ph66unfr06b0uin2i7j80t6f1i